|
Delayed
Nasdaq
14:23:05 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.3775 USD | -2.23% |
|
+7.37% | -24.20% |
| 09-11 | Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine | MT |
| 09-03 | Cosmos Health Inc. Reaffirms Earnings Guidance for the Year 2026, 2027 and 2029 | CI |
Company Valuation: Cosmos Health Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 48.22 | 18.78 | 14.06 | 17.39 | 38.85 | - |
| Change | - | -61.06% | -25.13% | 23.7% | 123.43% | - |
| Enterprise Value (EV) | 48.22 | 18.78 | 14.06 | 17.39 | 38.85 | 38.85 |
| Change | - | -61.06% | -25.13% | 23.7% | 123.43% | 0% |
| P/E | -0.14x | -0.66x | -0.57x | -0.79x | -1.84x | 5.52x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0x | -0x |
| Capitalization / Revenue | - | 0.35x | - | 0.27x | 0.48x | 0.35x |
| EV / Revenue | - | 0x | - | 0x | 0.48x | 0.35x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -33.16 | -2.15 | -1.17 | -0.63 | -0.21 | 0.07 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 53.38 | - | 65.27 | 80.8 | 110.8 |
| EBITDA | - | -21.24 | - | - | - | - |
| EBIT | - | -21.83 | - | - | - | - |
| Net income | -13.83 | -25.78 | -22.38 | -19.14 | - | - |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 4.5600 | 1.4100 | 0.6690 | 0.4980 | 0.3861 | 0.3861 |
| Nbr of stocks (in thousands) | 10,574 | 13,318 | 21,014 | 34,920 | 100,634 | - |
| Announcement Date | 4/12/23 | 8/5/24 | 4/15/25 | 4/15/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.84x | - | - | - | 38.85M | |
| 32.69x | 11.85x | 24.08x | 0.6% | 1,025B | |
| 28.77x | 6.4x | 17.91x | 2.06% | 623B | |
| 32.89x | 7.71x | 15.93x | 2.67% | 459B | |
| 104.62x | 5.85x | 24.82x | 2.37% | 355B | |
| 18.99x | 4.63x | 11.47x | 2.87% | 336B | |
| 20.13x | 5.23x | 12.95x | 3.06% | 270B | |
| 20.27x | 4.21x | 12x | 2.1% | 247B | |
| 25.72x | 6.72x | 11.97x | 2.48% | 220B | |
| -44.61x | 6.5x | 25.4x | 2.23% | 183B | |
| Average | 23.76x | 6.57x | 17.39x | 2.27% | 371.83B | |
| Weighted average by Cap. | 31.73x | 7.64x | 18.71x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COSM Stock
- Valuation Cosmos Health Inc.
Select your edition
All financial news and data tailored to specific country editions
